Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 12,932 | 16,696 | 14,771 | 17,652 | 15,942 |
| Operating Income | -12,932 | -16,696 | -14,771 | -17,652 | -15,942 |
| Other Income | 724 | 240 | 38 | 245 | 70 |
| Pre-tax Income | -12,208 | -16,457 | -14,733 | -17,407 | -15,873 |
| Income Tax | 11 | 26 | 9 | 9 | -7 |
| Net Income Continuous | -12,219 | -16,483 | -14,742 | -17,416 | -15,866 |
| Minority Interests | -3,214 | -9,271 | N/A | -5,262 | N/A |
| Net Income | $-9,005 | $-7,197 | $-14,742 | $-12,154 | $-15,880 |
| EPS Basic Total Ops | -0.23 | 2.08 | -0.27 | -0.34 | -3.17 |
| EPS Basic Continuous Ops | -0.31 | 1.86 | -0.40 | -0.49 | -3.16 |
| EPS Diluted Total Ops | -0.23 | 2.08 | -0.27 | -0.34 | -3.17 |
| EPS Diluted Continuous Ops | -0.31 | 1.86 | -0.40 | -0.49 | -3.16 |
| EBITDA(a) | $-12,928 | $-16,541 | $-14,767 | $-17,649 | $-15,940 |